Citizens National Bank Trust Department Abb Vie Inc. Transaction History

Citizens National Bank Trust Department

$474 Million
Q3 2024

A detailed history of Citizens National Bank Trust Department transactions in Abb Vie Inc. stock. As of the latest transaction made, Citizens National Bank Trust Department holds 38,943 shares of ABBV stock, worth $6.63 Million. This represents 1.62% of its overall portfolio holdings.

Number of Shares

38,943

Previous 38,758 0.48%

Holding current value

$6.63 Million

Previous $6.65 Million 15.69%

% of portfolio

1.62%

Previous 1.48%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$163.84 - $199.33 $30,310 - $36,876	185 Added 0.48%	38,943 $7.69 Million
Q2 2024 Jul 22, 2024	BUY	$154.79 - $180.76 $94,421 - $110,263	610 Added 1.6%	38,758 $6.65 Million
Q1 2024 May 03, 2024	SELL	$159.82 - $182.1 $101,485 - $115,633	-635 Reduced 1.64%	38,148 $6.95 Million
Q4 2023 Jan 29, 2024	SELL	$137.6 - $154.97 $30,272 - $34,093	-220 Reduced 0.56%	38,783 $6.01 Million
Q3 2023 Oct 25, 2023	SELL	$133.59 - $154.65 $101,795 - $117,843	-762 Reduced 1.92%	39,003 $5.81 Million
Q2 2023 Jul 24, 2023	SELL	$132.51 - $164.9 $310,073 - $385,866	-2,340 Reduced 5.56%	39,765 $5.36 Million
Q1 2023 May 03, 2023	SELL	$144.61 - $166.54 $127,979 - $147,387	-885 Reduced 2.06%	42,105 $6.71 Million
Q4 2022 Feb 09, 2023	SELL	$138.31 - $165.87 $21,576 - $25,875	-156 Reduced 0.36%	42,990 $6.95 Million
Q3 2022 Nov 08, 2022	SELL	$134.21 - $153.93 $4,697 - $5,387	-35 Reduced 0.08%	43,146 $5.79 Million
Q2 2022 Jul 28, 2022	BUY	$137.62 - $174.96 $1.76 Million - $2.24 Million	12,825 Added 42.25%	43,181 $6.61 Million
Q1 2022 May 10, 2022	SELL	$131.98 - $163.75 $43,553 - $54,037	-330 Reduced 1.08%	30,356 $4.46 Million
Q4 2021 Feb 15, 2022	SELL	$107.43 - $135.93 $1.38 Million - $1.74 Million	-12,814 Reduced 29.46%	30,686 $4.16 Million
Q3 2021 Nov 08, 2021	SELL	$106.4 - $120.78 $77,672 - $88,169	-730 Reduced 1.65%	43,500 $4.69 Million
Q2 2021 Aug 05, 2021	BUY	$105.21 - $117.21 $160,971 - $179,331	1,530 Added 3.58%	44,230 $4.98 Million
Q1 2021 May 10, 2021	BUY	$102.3 - $112.62 $265,468 - $292,248	2,595 Added 6.47%	42,700 $4.62 Million
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $8,048 - $10,867	100 Added 0.25%	40,105 $4.3 Million
Q2 2020 Aug 06, 2020	BUY	$73.37 - $98.18 $157,745 - $211,087	2,150 Added 5.68%	40,005 $3.93 Million
Q1 2020 Apr 28, 2020	BUY	$64.5 - $97.79 $2.44 Million - $3.7 Million	37,855 New	37,855 $2.88 Million

Others Institutions Holding ABBV

# of Institutions

3,817

Shares Held

1.25B

Call Options Held

13M

Put Options Held

10M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $301B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens National Bank Trust Department, based on Form 13F filings with the SEC.

News

Stay updated on Citizens National Bank Trust Department with notifications on news.

Account

Citizens National Bank Trust Department Abb Vie Inc. Transaction History